Femasys Inc. is projected to rise to $0.5686 by 2027, a +50% move from its current price of $0.378. FEMY is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $0.3582 | $0.3784 | $0.3998 | +0.11% |
| May 30 | $0.3505 | $0.3788 | $0.4094 | +0.22% |
| May 31 | $0.3448 | $0.3793 | $0.4171 | +0.33% |
| Jun 1 | $0.3402 | $0.3797 | $0.4237 | +0.44% |
| Jun 2 | $0.3362 | $0.3801 | $0.4297 | +0.55% |
| Jun 3 | $0.3326 | $0.3805 | $0.4353 | +0.66% |
| Jun 4 | $0.3294 | $0.3809 | $0.4405 | +0.77% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.3294 | $0.3809 | $0.4405 | +0.77% |
| Week 2 | $0.3126 | $0.3839 | $0.4714 | +1.55% |
| Week 3 | $0.3008 | $0.3868 | $0.4975 | +2.34% |
| Week 4 | $0.2915 | $0.3898 | $0.5213 | +3.13% |
| Week 5 | $0.2839 | $0.3929 | $0.5436 | +3.93% |
| Week 6 | $0.2774 | $0.3959 | $0.5651 | +4.74% |
| Week 7 | $0.2717 | $0.399 | $0.586 | +5.55% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Femasys Inc. is a biomedical company that develops and commercializes therapeutic and diagnostic products for women’s reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemSperm, a sperm handling kit; FemChec, a confirmation test for tubal patency; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; and FemCath, a cornual balloon catheter for selective tube evaluation.
It also provides FemBloc, a non-surgical female permanent birth control solution. The company offers its products to gynecological physicians, related healthcare professionals, and women’s healthcare provider organizations. Femasys Inc.
was incorporated in 2004 and is headquartered in Suwanee, Georgia.
Femasys Inc. (FEMY) is a healthcare company listed in the Healthcare sector. The current price is $0.378 and the market cap is $22.83M, with a market rank of 4861. The stock sits in a market where the near-term price action is framed by a neutral technical stance and a defined support and resistance setup.
A major floor 27.7% below — a decisive break under it would weaken the trend.
The nearest floor, 10.8% below — buyers have tended to step in here.
The nearest ceiling, 19.8% above — a clean break opens room to run.
A major ceiling 79.6% above — clearing it would confirm fresh momentum.
Key FEMY support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of FEMY market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.3828 | Sell | $0.387 | Sell |
| MA 10 | $0.3755 | Buy | $0.3846 | Sell |
| MA 20 | $0.3881 | Sell | $0.3902 | Sell |
| MA 50 | $0.424 | Sell | $0.4275 | Sell |
| MA 100 | $0.495 | Sell | $0.4935 | Sell |
| MA 200 | $0.5723 | Sell | $0.6055 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 46.58 | Neutral |
| Stoch RSI (14) | 52.82 | Neutral |
| CCI (20) | -25.19 | Neutral |
| Williams %R (14) | -63.39 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | -12.09 | Sell |
| Bollinger %B (20,2) | 0.42 | Neutral |
| Stochastic %K (14) | 36.61 | Neutral |
| TRIX (15) | -0.51 | Sell |
| Awesome (5,34) | -0.01 | Sell |
| Ultimate (7,14,28) | 48.87 | Neutral |
| Momentum (10) | 0.00 | Buy |
| Aroon Osc (25) | -44.00 | Sell |
| Hull MA (9) | 0.41 | Sell |
| ADX (14) | 18.64 | Neutral |
| ATR (14) | 0.02 | Info |
The 30-day technical picture is NEUTRAL. The RSI(14) is 50, with a SMA50 of $0.424 and a SMA200 of $0.5723. Immediate levels to watch are a support at $0.337 and a resistance at $0.453. The 30-day price range spans from $0.2632 to $0.5429, indicating limited volatility within that window. The annualized volatility is 100%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.337 | $0.378 | $0.6408 | 0% | Neutral | |
| $0.4092 | $0.5686 | $0.855 | +50% | Bullish | |
| $0.4718 | $0.6957 | $1.11 | +84% | Bullish | |
| $0.3894 | $0.6045 | $1.01 | +60% | Bullish | |
| $0.3549 | $0.5772 | $1.01 | +53% | Bullish | |
| $0.3302 | $0.5612 | $1.01 | +48% | Bullish | |
| $0.2859 | $0.5066 | $0.9417 | +34% | Bullish | |
| $0.4322 | $0.7975 | $1.52 | +111% | Bullish | |
| $0.4614 | $0.8857 | $1.73 | +134% | Bullish | |
| $0.3701 | $0.7383 | $1.48 | +95% | Bullish | |
| $0.4969 | $1.10 | $2.43 | +192% | Bullish | |
| $0.6163 | $1.37 | $3.15 | +262% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.337 | $0.378 | $0.4449 | +0.00% |
| June 2026 | $0.3202 | $0.3841 | $0.4772 | +1.60% |
| July 2026 | $0.3427 | $0.418 | $0.5327 | +8.83% |
| August 2026 | $0.3339 | $0.4126 | $0.5361 | -1.27% |
| September 2026 | $0.3335 | $0.4168 | $0.55 | +1.00% |
| October 2026 | $0.3694 | $0.4664 | $0.6241 | +11.91% |
| November 2026 | $0.3836 | $0.4887 | $0.662 | +4.79% |
| December 2026 | $0.3639 | $0.4677 | $0.6408 | -4.30% |
Click any year to see its month-by-month FEMY forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, FEMY is projected to trade between $0.337 and $0.6408, averaging $0.378 — a potential gain of 0% from today's $0.378. Price action looks broadly range-bound.
Femasys Inc.'s 2027 outlook centres on $0.5686, within a $0.4092 to $0.855 range. That is up +50% on the projected 2026 average. That marks a +50% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, FEMY could reach as high as $1.11, with a base case around $0.6957 and support toward $0.4718 — roughly +84% from $0.378. Momentum favours further upside here.
Expect FEMY to range from $0.3894 to $1.01 through 2029. The $0.6045 average target implies a +60% move from current prices. That is -13% versus the projected 2028 average. Buyers look set to stay in control over this stretch.
The FEMY price prediction for 2030 points to an average of $0.5772 (low $0.3549, high $1.01) — a potential gain of +53% on today's $0.378. Momentum favours further upside here.
In 2031, FEMY is projected to trade between $0.3302 and $1.01, averaging $0.5612 — a potential gain of +48% from today's $0.378. That is -3% versus the projected 2030 average. Buyers look set to stay in control over this stretch.
Femasys Inc.'s 2032 outlook centres on $0.5066, within a $0.2859 to $0.9417 range. That is -10% versus the projected 2031 average. That marks a +34% change versus current levels. Momentum favours further upside here.
By 2033, FEMY could reach as high as $1.52, with a base case around $0.7975 and support toward $0.4322 — roughly +111% from $0.378. Buyers look set to stay in control over this stretch.
Expect FEMY to range from $0.4614 to $1.73 through 2034. The $0.8857 average target implies a +134% move from current prices. That is up +11% on the projected 2033 average. Momentum favours further upside here.
The FEMY price prediction for 2035 points to an average of $0.7383 (low $0.3701, high $1.48) — a potential gain of +95% on today's $0.378. Buyers look set to stay in control over this stretch.
In 2040, FEMY is projected to trade between $0.4969 and $2.43, averaging $1.10 — a potential gain of +192% from today's $0.378. That is up +50% on the projected 2035 average. Momentum favours further upside here.
Femasys Inc.'s 2050 outlook centres on $1.37, within a $0.6163 to $3.15 range. That is up +24% on the projected 2040 average. That marks a +262% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in FEMY today (≈ 2,645.502646 FEMY) could be worth
$3,623.1
+$2,623.1 (+262%) by 2050 · US Dollar
Based on the average projected FEMY price of $1.37 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in FEMYwould be worth at today's price.
$1,000 invested in FEMY on May 27, 2025 (≈ 961.538497 FEMY) would be worth
$363.46
-$636.54 (-63.7%) today · 0.36× · US Dollar
Based on a FEMY entry price of $1.04 vs. today's $0.378.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.351 | $1,076.92 | +7.7% |
| 1 month ago | $0.391 | $966.75 | -3.3% |
| 3 months ago | $0.558 | $677.42 | -32.3% |
| 6 months ago | $1.01 | $374.26 | -62.6% |
| 1 year ago | $1.04 | $363.46 | -63.7% |
| All time (4.9y) ago | $12 | $31.5 | -96.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our FEMY forecast.
Our base-case forecast reaches $0.76 around 2033.
Implied market cap at $0.76: $45.9M
The multi-year forecast shows a bullish trajectory after 2026, with the average price rising over time and notable upside potential. In 2026 the avg is $0.378 with a min of $0.337 and a max of $0.6408 (ROI 0, sentiment NEUTRAL), while 2027-2035 show continued bullish sentiment and rising averages, culminating in 2030 with an avg of $0.5772 and a max of $1.01 (ROI 52.7%). By 2040 the avg is $1.10 with a max of $2.43 (ROI 192.1%), and by 2050 the avg reaches $1.37 with a max of $3.15 (ROI 262.3%).
The forecast for 2033–2035 remains bullish with substantial upside, reinforcing a longer horizon of potential growth but also underscoring the uncertainty inherent in such estimates. These are estimates, not guarantees, and real outcomes can differ.
Tap a question to reveal the answer.
By 2030, the forecast lists an avg price of $0.5772 with a min of $0.3549 and a max of $1.01, and an ROI of 52.7% with a bullish sentiment.
The forecast shows bullish sentiment from 2027 onward with rising averages and sizable upside, including an avg of $0.5686 in 2027 (ROI 50.4%); by 2040 the avg is $1.10 (ROI 192.1%), and by 2050 the avg is $1.37 (ROI 262.3%). Note that 2026 is neutral with an avg of $0.378 (ROI 0%).
Yes. The forecast max reaches $2.43 by 2040 and $3.15 by 2050, with intermediate years showing smaller tops (for example, 2033 max $1.52 and 2034 max $1.73).
Current price is $0.378 and market cap is $22.83M.
The 30-day technical picture is NEUTRAL with RSI(14) at 50, SMA50 at $0.424, SMA200 at $0.5723, a support level of $0.337, and a resistance level of $0.453. The 30-day price range is $0.2632 to $0.5429 and annualized volatility is 100%.
Femasys Inc. Community Discussion
0Share your Femasys Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.